These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12147661)

  • 1. Laboratory investigations following an unexpectedly positive crossmatch result in a patient awaiting renal transplantation.
    Cole J; Wortley A; Stoves J; Clark B
    J Clin Pathol; 2002 Aug; 55(8):627-8. PubMed ID: 12147661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
    Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching.
    Karuppan SS; Lindholm A; Möller E
    Transplantation; 1992 Mar; 53(3):666-73. PubMed ID: 1549863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive virtual crossmatch with negative flow crossmatch results in two cases.
    Jacob EK; De Goey SR; Gandhi MJ
    Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luminex-based virtual crossmatching for renal transplantation in South Africa.
    Worsley CM; Mayne ES; Suchard MS
    S Afr Med J; 2011 Dec; 102(1):40-3. PubMed ID: 22273137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual crossmatch in kidney transplantation.
    Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
    Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation in a recipient with anti-HLA antibody IgM positive.
    Suzuki M; Ishida H; Komatsu T; Kennoki T; Ishizuka T; Tanabe K
    Transpl Immunol; 2009 Jul; 21(3):150-4. PubMed ID: 19356741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study.
    Kim DG; Lee J; Park Y; Kim MS; Jeong HJ; Kim SI; Kim YS; Kim BS; Huh KH
    BMC Nephrol; 2019 Dec; 20(1):456. PubMed ID: 31818254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is flow cytometry crossmatch analysis using sera with different dilutions important for pretransplant analysis? A case report.
    Sağıroğlu T; Tozkır H; Kılıçarslan-Ayna T; Yağcı MA; Sezer A; Carin M
    Transplant Proc; 2012; 44(6):1767-9. PubMed ID: 22841268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting flow cytometry crossmatch results from single-antigen bead testing.
    Flynn PA; Fernando S; Worthington JE; Poulton KV
    Int J Immunogenet; 2024 Apr; 51(2):93-99. PubMed ID: 38374539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?
    Pereira S; Perkins S; Lee JH; Shumway W; LeFor W; Lopez-Cepero M; Wong C; Connolly A; Tan JC; Grumet FC
    Hum Immunol; 2011 Jun; 72(6):492-8. PubMed ID: 21396421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.